CDKN2A and carcinoma: Upregulation of p16 at both the mRNA and protein level in a small number of carcinomas and cell lines compared to normal tissue was reported in one study,30 while another reported a 6‐fold increase in p16 mRNA expression in high‐grade cytology specimens compared to normal cells and HPV‐negative women.31